A Comparative Study to Evaluate the Efficacy of Virechan Karma and Vasti Karma in Cases of Vatarakta w.s.r. to Gouty Arthritis

Majority of people globally have shown keen interest in Ayurveda as awareness has increased because of adverse effects of powerful modern synthetic drugs. In recent years, the miscellaneous groups of disease primarily involving the musculoskeletal structures have been the subjects of intense study and Vatarakta is one of them. Vatarakta is a well-documented disease in Ayurvedic classics. It described as a pathological condition arising from the simultaneous vitiation of Vata and Rakta by distinct etiological factors and generate the Samprapti of Avarana. A comparative understanding of Vatarakta and gouty arthritis reveals significant overlaps in their etiopathogenesis and symptomatology. Both conditions involve derangements in systemic metabolism, peripheral inflammation, episodic flares, chronicity, and multisystem involvement. Materials and Method: For this study 100 patients having Sandhishu Ruk (joint pain), Swathu (swelling), Sparsh-ashatvam (tenderness), Stabdhta (restricted movements of joints), Daha (burning), Kandu (itching), and Vaivarnyata (skin discoloration). With raised serum uric acid level were registered. All patients were divided in two groups 50 patients in each. In Group A Virechana with Aragvadha phala majja and in Group B Vasti with Guduchiadi taila and Guduchi kwath were given. Guggulu vati common in both groups. Type of study: Phase-2 Randomized parallel group study. Results: The trial drugs show a significant result on the subjective symptoms and objective parameters like serum uric acid level. Conclusion: Vasti karma was more effective in reducing clinical symptoms and s. uric acid level as compared to Virechana.